Reflections on the meningococcal group C infection immunisation campaign: views from the sharp end.
In July 1999, the Department of Health launched a campaign to immunise all children aged from 0-17 years with a new vaccine giving protection against meningococcal group C infection. Following the campaign, a survey of Immunisation Co-ordinators in England was conducted to identify strengths and weaknesses of the campaign. This paper summarises the main findings.
Lansley
M
M
Children's Services, Skimped Hill Health Centre, Market Place, Bracknell, Berkshire RG12 1LH, UK. marilynlansley@aol.com
Bedford
H
H
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D006801:Humans; D017589:Immunization Programs; D007223:Infant; D007231:Infant, Newborn; D008589:Meningococcal Infections / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000276:immunology*; D038542:Neisseria meningitidis, Serogroup C / Q000378:metabolism*; D033282:Parental Consent; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage* / Q000276:immunology; D011795:Surveys and Questionnaires; D006113:United Kingdom / Q000453:epidemiology
D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; C037676:meningococcal group C polysaccharide